Crisis in INBio

Ken Kinman kinman2 at YAHOO.COM
Wed Aug 24 13:24:19 CDT 2005

If it is true, it's certainly sad.  When money gets tight, the capitalistic way is to cut jobs whether it makes long-term sense or not.  Perhaps an unfortunate over-reliance on pharmaceutical partnerships (and future meager royalties, if they materialize at all).  With Merck and other such companies now under a great deal of liability stress, those funding sources will probably all but dry up.  Things will probably get worse before they get better.

George Beccaloni wrote:

Dear All,
I believe that INBio in Costa Rica is experiencing a funding crisis and that they are about to make many of their scientists redundant.  Does anyone know any more about this?

More information about the Taxacom mailing list